BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35714314)

  • 21. Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers.
    Feng S; Cheng X; Zhang L; Lu X; Chaudhary S; Teng R; Frederickson C; Champion MM; Zhao R; Cheng L; Gong Y; Deng H; Lu X
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10094-10099. PubMed ID: 30232256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
    Xu LH; Wang Y; Chen ZY; Fang JP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association analysis of the lymphocyte-specific protein tyrosine kinase (LCK) gene in type 1 diabetes.
    Hulme JS; Barratt BJ; Twells RC; Cooper JD; Lowe CE; Howson JM; Lam AC; Smink LJ; Savage DA; Undlien DE; Guja C; Ionescu-Tîirgoviste C; Tuomilehto-Wolf E; Tuomilehto J; Todd JA
    Diabetes; 2004 Sep; 53(9):2479-82. PubMed ID: 15331563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.
    Choi YB; Son M; Park M; Shin J; Yun Y
    J Biol Chem; 2010 Mar; 285(10):7271-80. PubMed ID: 20007709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of the CD8alpha/p56(lck) protein complex in stably expressing rat epithelial cells.
    Pascale MC; Remondelli P; Leone A; Bonatti S
    FEBS Lett; 2000 Sep; 480(2-3):226-30. PubMed ID: 11034334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Pyk2 expression by p56(Lck) in Jurkat T lymphocytes.
    Franklin RA; Atherfold PA; Robinson PJ; Bonner D
    Cell Signal; 2001 Jan; 13(1):65-9. PubMed ID: 11257449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia.
    Greenland NY; Van Ziffle JA; Liu YC; Qi Z; Prakash S; Wang L
    Hum Pathol; 2021 Feb; 108():76-83. PubMed ID: 33232718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p56Lck tyrosine kinase enhances the assembly of death-inducing signaling complex during Fas-mediated apoptosis.
    Sharif-Askari E; Gaucher D; Halwani R; Ma J; Jao K; Abdallah A; Haddad EK; Sékaly RP
    J Biol Chem; 2007 Dec; 282(49):36048-56. PubMed ID: 17932036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.
    Skalska-Sadowska J; Januszkiewicz-Lewandowska D; Derwich K; Pieczonka A; Samborska M; Wachowiak J
    Pediatr Blood Cancer; 2015 Jun; 62(6):1070-1. PubMed ID: 25631405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of human tyrosine kinase, Lck, in yeast Saccharomyces cerevisiae: growth suppression and strategy for inhibitor screening.
    Koyama M; Saito S; Nakagawa R; Katsuyama I; Hatanaka M; Yamamoto T; Arakawa T; Tokunag M
    Protein Pept Lett; 2006; 13(9):915-20. PubMed ID: 17100647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
    Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
    Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testicular myeloid sarcoma: a rare manifestation of acute myeloid leukemia in an infant.
    Tran CN; Collie AM; Flagg A; Rhee A
    Urology; 2014 Oct; 84(4):925-7. PubMed ID: 25260454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell.
    Torigoe T; Millan JA; Chan KW; Taichman R; Brian AA; Reed JC; Tachman R [corrected to Taichman R]
    J Exp Med; 1994 Sep; 180(3):1115-27. PubMed ID: 7914906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemia.
    Yoshiki Y; Asai T; Ichikawa M; Hangaishi A; Ota S; Imai Y; Takahashi T; Kurokawa M
    Intern Med; 2011; 50(21):2649-52. PubMed ID: 22041374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
    Sugihara T; Werneburg NW; Hernandez MC; Yang L; Kabashima A; Hirsova P; Yohanathan L; Sosa C; Truty MJ; Vasmatzis G; Gores GJ; Smoot RL
    Mol Cancer Res; 2018 Oct; 16(10):1556-1567. PubMed ID: 29903769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.
    Laguette N; Brégnard C; Bouchet J; Benmerah A; Benichou S; Basmaciogullari S
    J Virol; 2009 Jul; 83(14):7117-28. PubMed ID: 19439470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization, tissue expression, polymorphism and association of porcine LCK gene.
    Yonggang L; Xueshan X
    Mol Biol Rep; 2012 Apr; 39(4):4023-8. PubMed ID: 21779804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
    Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
    Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature.
    Vera-Aguilera J; Mukarram O; Nutalapati P; Mok M; Bulumulle A; Vera-Aguilera C
    J Med Case Rep; 2016 Feb; 10():31. PubMed ID: 26846095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignancies.
    Rouer E; Dreyfus F; Melle J; Ribrag V; Benarous R
    Leukemia; 1993 Feb; 7(2):246-50. PubMed ID: 8426478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.